BACKGROUND: Cystathionine β-synthase (CBS), one of three enzymes that endogenously produce hydrogen sulfide, is extensively studied for its relevance in the cells of various tumors. In our previous work, we observed that the immunofluorescence pattern of CBS is very similar to that of tubulin and actin. Therefore, we focused on the potential interaction of CBS with cytoskeletal proteins β-actin and β-tubulin and the functional relevance of the potential interaction of these proteins in colorectal carcinoma cell lines. METHODS: To study the potential interaction of CBS with cytoskeletal proteins and its functional consequences, a CBS-knockout DLD1 (DLDx) cell line was established by using the CRISPR/Cas9 gene editing method. The interaction of the selected cytoskeletal protein with CBS was studied by immunoprecipitation, Western blot analysis, immunofluorescence, and proximity ligation assay. The functional consequences were studied by proliferation and migration assays and by generation of xenografts in SCID/bg mice. RESULTS: We have found that CBS, an enzyme that endogenously produces H2S, binds to cytoskeletal β-tubulin and, to a lesser extent, also to β-actin in colorectal carcinoma-derived cells. When CBS was knocked out by the CRISPR/Cas9 technique (DLDx), we observed a de-arranged cytoskeleton compared to the unmodified DLD1 cell line. Treatment of these cells with a slow sulfide donor GYY4137 resulted in normal organization of the cytoskeleton, thus pointing to the role of CBS in microtubule dynamics. To evaluate the physiological importance of this observation, both DLD1 and DLDx cells were injected into SCID/bg mice, and the size and mass of the developed xenografts were evaluated. Significantly larger tumors developed from DLDx compared to the DLD1 cells, which correlated with the increased proliferation of these cells. CONCLUSIONS: Taken together, in colorectal cancer DLD1 cells, CBS binds to the cytoskeleton, modulates microtubule dynamics, and thus affects the proliferation and migration in the colorectal carcinoma stable cell line.

Cancer Research Institute Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Department of Physiology Faculty of Medicine Masaryk University Brno Czechia

Institute of Clinical and Translational Research Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Institute of Virology Biomedical Research Center Slovak Academy of Sciences Bratislava Slovakia

Zobrazit více v PubMed

Panagaki T, Randi EB, Augsburger F, Szabo C. Overproduction of H2S, generated by CBS, inhibits mitochondrial complex IV and suppresses oxidative phosphorylation in down syndrome. Proc Natl Acad Sci USA (2019) 116:18769–71. doi: 10.1073/pnas.1911895116 PubMed DOI PMC

Zuhra K, Augsburger F, Majtan T, Szabo C. Cystathionine-β-synthase: molecular regulation and pharmacological inhibition. Biomolecules (2020) 10:697. doi: 10.3390/biom10050697 PubMed DOI PMC

McCorvie TJ, Bailey HJ, Strain-Damerell C, Basle A, Yue WW. Architecture and regulation of filamentous human cystathionine beta-synthase. bioRxiv (2023), 2023–02. doi: 10.1101/2023.02.15.528523 PubMed DOI PMC

Weiss N, Heydrick S, Zhang YY, Bierl C, Cap A, Loscalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler Thromb Vasc Biol (2002) 22:34–41. doi: 10.1161/hq1201.100456 PubMed DOI

Comas F, Latorre J, Ortega F, Oliveras-Cañellas N, Lluch A, Ricart W, et al. . Permanent cystathionine-β-synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity. Redox Biol (2020) 2:101668. doi: 10.1016/j.redox.2020 PubMed DOI PMC

Fox B, Schantz JT, Haigh R, Wood ME, Moore PK, Viner N, et al. . Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint? J Cell Mol Med (2010) 16:896–910. doi: 10.1111/j.1582-4934.2011.01357.x PubMed DOI PMC

Szabo C, Coletta C, Chao C, Módis K, Szczesny B, Papapetropoulos A, et al. . Tumor-derived hydrogen sulfide, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci USA (2013) 110:12474–9. doi: 10.1073/pnas.1306241110 PubMed DOI PMC

Yue T, Zuo S, Bu D, Zhu J, Chen S, Ma Y, et al. . Aminooxyacetic acid (AOAA) sensitizes colon cancer cells to oxaliplatin via exaggerating apoptosis induced by ROS. J Cancer. (2020) 11:1828–38. doi: 10.7150/jca.35375 PubMed DOI PMC

Guo H, Gai JW, Wang Y, Jin HF, Du JB, Jin J. Characterization of hydrogen sulfide and its synthases, cystathionine β-synthase and cystathionine γ-lyase, in human prostatic tissue and cells. Urology (2012) 79:483–e1-5. doi: 10.1016/j.urology.2011.10.013 PubMed DOI

Turbat-Herrera EA, Kilpatrick MJ, Chen J, Meram AT, Cotelingam J, Ghali G, et al. . Cystathione β-synthase is increased in thyroid malignancies. Anticancer Res (2018) 38:6085–90. doi: 10.21873/anticanres.12958 PubMed DOI PMC

Bhattacharyya S, Saha S, Giri K, Lanza IR, Nair KS, Jennings NB, et al. . Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance. PloS One (2013) 8:e79167. doi: 10.1371/journal.pone.0079167 PubMed DOI PMC

Sen S, Kawahara B, Gupta D, Tsai R, Khachatryan M, Roy-Chowdhuri S, et al. . Role of cystathionine β-synthase in human breast cancer. Free Radic Biol Med (2015) 86:228–38. doi: 10.1016/j.freeradbiomed.2015.05.024 PubMed DOI

Santos I, Ramos C, Mendes C, Sequeira CO, Tomé CS, Fernandes DGH, et al. . Targeting glutathione and cystathionine β-synthase in ovarian cancer treatment by selenium-chrysin polyurea dendrimer nanoformulation. Nutrients (2019) 11:2523. doi: 10.3390/nu11102523 PubMed DOI PMC

Breza J, Soltysova A, Hudecova S, Penesova A, Szadvari I, Babula P, et al. . Endogenous H2S producing enzymes are involved in apoptosis induction in clear cell renal cell carcinoma. BMC Cancer. (2018) 18:591. doi: 10.1186/s12885-018-4508-1 PubMed DOI PMC

Dongsoo K, Chen J, Wei E, Ansari J, Meram A, Patel S, et al. . Hydrogen sulfide and hydrogen sulfide-synthesizing enzymes are altered in a case of oral adenoid cystic carcinoma. Case Rep Oncol (2018) 11:585–90. doi: 10.1159/000492464 PubMed DOI PMC

Cao X, Ding L, Xie ZZ, Yang Y, Whiteman M, Moore PK, et al. . A review of hydrogen sulfide synthesis, metabolism, and measurement: is modulation of hydrogen sulfide a novel therapeutic for cancer? Antioxid Redox Signal (2019) 11:1–38. doi: 10.1089/ars.2017.7058 PubMed DOI PMC

Lu S, Gao Y, Huang X, Wang X. GYY4137, a hydrogen sulfide (H2S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway. Int J Oncol (2014) 44:1259–67. doi: 10.1016/j.niox.2019.02.011 PubMed DOI

Szadvari I, Hudecova S, Chovancova B, Matuskova M, Cholujova D, Lencesova L, et al. . Sodium/calcium exchanger is involved in apoptosis induced by H2S in tumor cells through decreased levels of intracellular pH. Nitric Oxide (2019) 87:1–9. doi: 10.1016/j.niox.2019.02.011 PubMed DOI

Teng H, Wu B, Zhao K, Yang G, Wu L, Wang R. Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease. Proc Natl Acad Sci USA (2013) 110:12679–84. doi: 10.1073/pnas.1308487110 PubMed DOI PMC

Szabo C, Ransy C, Módis K, Andriamihaja M, Murghes B, Coletta C, et al. . Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Br J Pharmacol (2014) 171:2099–122. doi: 10.1111/bph.12369 PubMed DOI PMC

Parker AL, Teo WS, McCarroll JA, Kavallaris M. An emerging role for tubulin isotypes in modulating cancer biology and chemotherapy resistance. Int J Mol Sci (2017) 18:1434. doi: 10.3390/ijms18071434 PubMed DOI PMC

Chaudhuri AR, Khan IA, Luduena RF. Detection of disulfide bonds in bovine brain tubulin and their role in protein folding and microtubule assembly in vitro: a novel disulfide detection approach. Biochemistry (2001) 40:8834–41. doi: 10.1021/bi0101603 PubMed DOI

Mustafa AK, Gadalla MM, Sen N, Kim S, Mu W, Gazi SK, et al. . H2S signals through protein s-sulfhydration. Sci Signal (2014) 2:ra72. doi: 10.1126/scisignal.2000464 PubMed DOI PMC

Hosono T, Fukao T, Ogihara J, Ito Y, Shiba H, Seki T, et al. . Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin. J Biol Chem (2005) 280:41487–93. doi: 10.1074/jbc.M507127200 PubMed DOI

Steinmetz MO, Prota AE. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol (2018) 28:776–92. doi: 10.1016/j.tcb.2018.05.001 PubMed DOI

Lencesova L, Hudecova S, Csaderova L, Markova J, Soltysova A, Pastorek M, et al. . Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. Acta Physiol (2013) 208:350–61. doi: 10.1111/apha.12105 PubMed DOI

Markova J, Hudecova S, Soltysova A, Sirova M, Csaderova L, Lencesova L, et al. . Sodium/calcium exchanger is upregulated by sulfide signaling, forms complex with the β1 and β3 but not β2 adrenergic receptors, and induces apoptosis. Pflugers Arch (2014) 466:1329–42. doi: 10.1007/s00424-013-1366-1 PubMed DOI

Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods (2014) 11:783–4. doi: 10.1038/nmeth.3047 PubMed DOI PMC

Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, et al. . Genome-scale CRISPR-Cas9 knockout screening in human cells. Science (2014) 343:84–7. doi: 10.1126/science.1247005 PubMed DOI PMC

Rezuchova I, Hudecova S, Soltysova A, Matuskova M, Durinikova E, Chovancova B, et al. . Type 3 inositol 1,4,5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells. Cell Death Dis (2019) 10:186. doi: 10.1038/s41419-019-1433-4 PubMed DOI PMC

Liskova V, Hudecova S, Lencesova L, Iuliano F, Sirova M, Ondrias K, et al. . Type 1 sodium calcium exchanger forms a complex with carbonic anhydrase IX and Via reverse mode activity contributes to pH control in hypoxic tumors. Cancers (Basel). (2019) 11(8):1139. doi: 10.3390/cancers11081139 PubMed DOI PMC

Ouyang J, Qin G, Liu Z, Jian X, Shi T, Xie L. ToPP: tumor online prognostic analysis platform for prognostic feature selection and clinical patient subgroup selection. iScience 25 (2022) 5:104190. doi: 10.1016/j.isci.2022.104190 PubMed DOI PMC

Borys F, Joachimiak E, Krawczyk H, Fabczak H. Intrinsic and extrinsic factors affecting microtubule dynamics in normal and cancer cells. Molecules (2020) 25:3705. doi: 10.3390/molecules25163705 PubMed DOI PMC

Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature (1979) 277:665–7. doi: 10.1038/277665a0 PubMed DOI

Kajsik M, Chovancova B, Liskova V, Babula P, Krizanova O. Slow sulfide donor GYY4137 potentiates effect of paclitaxel on colorectal carcinoma cells. Eur J Pharmacol (2022) 922:174875. doi: 10.1016/j.ejphar.2022.174875 PubMed DOI

Britto PJ, Knipling L, Wolff J. The local electrostatic environment determines cysteine reactivity of tubulin. J Biol Chem (2002) 277:29018–27. doi: 10.1074/jbc.M204263200 PubMed DOI

Szabo C. Gasotransmitters in cancer: from pathophysiology to experimental therapy. Nat Rev Drug Discovery (2016) 15(3):185–203. doi: 10.1038/nrd.2015.1 PubMed DOI PMC

Kim J, Hong SJ, Park JH, Park SY, Kim SW, Cho EY, et al. . Expression of cystathionine beta-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol Rep (2009) 21(6):1449–54. doi: 10.3892/or_00000373 PubMed DOI

Gai JW, Qin W, Liu M, Wang HF, Zhang M, Li M, et al. . Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder. Urologic Oncol (2016) 34(4):166.e15–166.e1.66E20. doi: 10.16/j.urolonc.2015.06.020 PubMed DOI

Zhao H, Li Q, Wang J, Su X, Ng KM, Qiu T, et al. . Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer. PloS One (2012) 7(11):e49683. doi: 10.1371/journal.pone.0049683 PubMed DOI PMC

Padmanabhan N, Kyon HK, Boot A, Lim K, Srivastava S, Chen S, et al. . Highly recurrent CBS epimutations in gastric cancer CpG island methylator phenotypes and inflammation. Genome Biol (2021) 22(1):181. doi: 10.1186/s13059-021-02405-z PubMed DOI PMC

Britto PJ, Knipling L, McPhie P, Wolff J. Thiol-disulphide interchange in tubulin: kinetics and the effect on polymerization. Biochem J (2005) 389:549–58. doi: 10.1042/BJ20042118 PubMed DOI PMC

Li L, Whiteman M, Guan YY, Neo KL, Cheng Y, Lee SW, et al. . Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137). Circulation (2008) 117:2351–60. doi: 10.1161/CIRCULATIONAHA.107.753467 PubMed DOI

Zhang Y, Chen S, Zhu J, Guo S, Yue T, Xu H, et al. . Overexpression of CBS/H2S inhibits proliferation and metastasis of colon cancer cells through downregulation of CD44. Cancer Cell Int (2022) 22(1):85. doi: 10.1186/s12935-022-02512-2 PubMed DOI PMC

Módis K, Coletta C, Asimakopoulou A, Szczesny B, Chao C, Papapetropoulos A, et al. . Effect of s-adenosyl-L-methionine (SAM), an allosteric activator of cystathionine-β-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro . Nitric Oxide (2014) 41:146–56. doi: 10.1016/j.niox.2014.03.001 PubMed DOI PMC

Chao C, Zatarain JR, Ding Y, Coletta C, Mrazek AA, Druzhyna N, et al. . Cystathionine-β-synthase inhibition for colon cancer: enhancement of the efficacy of aminooxyacetic acid via the prodrug approach. Mol Med (2016) 22:361–79. doi: 10.2119/molmed.2016.00102 PubMed DOI PMC